Abstract
We review in this paper the role of heparin-binding growth factor (HBGF*) or fibroblast growth factor (FGF*), rat prostate cancer cells produce TGF-beta, IGF-II* and OGF*. Of these growth factors, TGF-beta and unknown labile factor with 19 kDa are the most probable candidates responsible for osteoblastic bony metastasis of prostate cancer. In vitro experiments suggest that TGF-beta modulates cell detachment of prostate cancer cells together with nutritional factors. HBGF-dependent growth of the prostate tumor epithelial cells is free form inhibition by TGF-beta, whereas normal prostate epithelial cells are sensitive to TGF-beta inhibition. Transfection experiments suggest that HBGF-2 (basic FGF) might be closely related to the malignant growth of prostate cancer, in addition to tumor angiogenesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Matuo Y., Nishi N., Matsui S., Sandberg A.A., Isaacs J.T. and Wada F., Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates, partial purification and characterization of rat prostatic growth factor in the Dunning tumor, Cancer Res. 47:188–192 (1987).
Mansson P-E., Adams P., Kan M. and McKeehan W.L., Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors, Cancer Res. 49:2485–2494 (1989).
Nishi N., Matuo Y., Muguruma Y., Yoshitake Y., Nishikawa K. and Wada F., A human prostatic growth factor (hPGF): Partial purification and characterization, Biochem. Biophys. Res.Commun. 132:1103–1109 (1985).
Story M.T., Sasse J., Jacobs SC and Lawson R.K., Prostatic growth factor: Purification and structural relationship to basic fibroblast growth factor, Biochemistry 26:3843–3849 (1987).
Nishi N., Matuo Y. and Wada F., Partial purification of a major type of rat prostatic growth factors: Characterization as an epidermal growth factor-related mitogen, The Prostate 13:209–220 (1988).
Matuo Y., Nishi N., Tanaka H., Sasaki I., Isaacs J.T. and Wada F., Production of IGF-II-related peptide by an anaplastic cell line (AT-3) established from the Dunning prostatic carcinoma of rats, Vitro Cell & Develop. Biol. 24:1053–1056 (1988).
Ikeda T., Lioubin M.N. and Marquardt H., Human transforming growth factor type beta 2: Production by a prostatic adenocarcinoma cell line. purification, and initial characterization, Biochemistry 26:2406–2410 (1987).
Matuo Y., Nishi N., Takasuka H., Masuda Y., Nishikawa K., Isaacs J.T., Adams P.S., McKeehan W.L. and Sata G.H., Production and significance of TGF-beta in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma, Biochem. Biophys. Res. Commun. 166:840–847 (1990).
Matuo Y., Prostatic growth factors (Pr GFs) — From the identification of probasin to the role of Pr GFs, in: “Molecular and Cellular Biology of Prostate Cancer”, pp 157–165, Karr J.P., Coffey D.S., Smith R.G., Tindell D.G., eds., Plenum Press, New York (1991).
Goltzman D., in this proceeding (1992).
Nishi N., Matuo Y. Kunitomi K., Takenaka I., Usami M., Kotake T., Wada F., Comparative analysis of growth factors in normal and pathologic human prostates, The Prostate, 13:39–48 (1988)
Matuo Y., Nishi N. and Wada F., Prostatic growth factor (PGF), in: “Prostate Cancer: The Second Tokyo Symposium,” pp 45–60, Kan J.P. Yamanaka H. eds., Elsevier Science Publishing Co., Inc. (1989).
Tanaka H., Asami O., Hayano T., Sasaki I., Yoshitake Y. and Nishikawa K, Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: Application of a monoclonal antibody, Endocrinol 124:870–877 (1989).
McKeehan W.L. and Adams P.S, Heparin-binding growth factor/Prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta, In Vitro Cell & Dev. Biol. 24:243–246 (1988).
McKeehan W.L., Kan M., Hou J., Wang F., Adams P. and Mansson P-E., Heparin-binding (fibroblast) growth factor/receptor gene expression in the prostate, in: “Molecular and Cellular Biology of Prostate Cancer”, pp 115–126, Kan J.P., Coffey D.S., Smith R.G., Tindell D.G., eds, Plenum Press, New York (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Matuo, Y. et al. (1992). Potential Role of HBGF (FGF) and TGF-Beta on Prostate Growth. In: Karr, J.P., Yamanaka, H. (eds) Prostate Cancer and Bone Metastasis. Advances in Experimental Medicine and Biology, vol 324. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3398-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3398-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6501-3
Online ISBN: 978-1-4615-3398-6
eBook Packages: Springer Book Archive